These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15741746

  • 1. Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram.
    Moeller O, Hetzel G, Michael N, Rothermundt M, Arolt V, Erfurth A.
    Neuropsychobiology; 2005; 51(2):67-71. PubMed ID: 15741746
    [Abstract] [Full Text] [Related]

  • 2. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.
    Juckel G, Pogarell O, Augustin H, Mulert C, Müller-Siecheneder F, Frodl T, Mavrogiorgou P, Hegerl U.
    J Clin Psychiatry; 2007 Aug; 68(8):1206-12. PubMed ID: 17854244
    [Abstract] [Full Text] [Related]

  • 3. The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients.
    Hetzel G, Moeller O, Erfurth A, Michael N, Rothermundt M, Arolt V, Evers S.
    Pharmacopsychiatry; 2004 Sep; 37(5):200-5. PubMed ID: 15470798
    [Abstract] [Full Text] [Related]

  • 4. Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.
    Seedat S, van Rheede van Oudtshoorn E, Muller JE, Mohr N, Stein DJ.
    Int Clin Psychopharmacol; 2003 Sep; 18(5):279-84. PubMed ID: 12920388
    [Abstract] [Full Text] [Related]

  • 5. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients.
    Tranter R, Bell D, Gutting P, Harmer C, Healy D, Anderson IM.
    J Affect Disord; 2009 Nov; 118(1-3):87-93. PubMed ID: 19250683
    [Abstract] [Full Text] [Related]

  • 6. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.
    Rampello L, Chiechio S, Nicoletti G, Alvano A, Vecchio I, Raffaele R, Malaguarnera M.
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):73-8. PubMed ID: 14685645
    [Abstract] [Full Text] [Related]

  • 7. No effects of antidepressants on negative symptoms in schizophrenia.
    Hinkelmann K, Yassouridis A, Kellner M, Jahn H, Wiedemann K, Raedler TJ.
    J Clin Psychopharmacol; 2013 Oct; 33(5):686-90. PubMed ID: 23857309
    [Abstract] [Full Text] [Related]

  • 8. Treatment effects of serotonergic and noradrenergic antidepressants on the intensity dependence of auditory ERP components in major depression.
    Linka T, Sartory G, Wiltfang J, Müller BW.
    Neurosci Lett; 2009 Sep 29; 463(1):26-30. PubMed ID: 19616062
    [Abstract] [Full Text] [Related]

  • 9. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression.
    Andreoli V, Caillard V, Deo RS, Rybakowski JK, Versiani M.
    J Clin Psychopharmacol; 2002 Aug 29; 22(4):393-9. PubMed ID: 12172339
    [Abstract] [Full Text] [Related]

  • 10. Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
    Wiles NJ, Mulligan J, Peters TJ, Cowen PJ, Mason V, Nutt D, Sharp D, Tallon D, Thomas L, O'Donovan MC, Lewis G.
    Br J Psychiatry; 2012 Feb 29; 200(2):130-6. PubMed ID: 22194183
    [Abstract] [Full Text] [Related]

  • 11. Citalopram plus reboxetine in treatment-resistant depression.
    Devarajan S, Dursun SM.
    Can J Psychiatry; 2000 Jun 29; 45(5):489-90. PubMed ID: 10900531
    [No Abstract] [Full Text] [Related]

  • 12. Effects of serotonergic and noradrenergic antidepressants on auditory startle response in patients with major depression.
    Quednow BB, Kühn KU, Stelzenmuelle R, Hoenig K, Maier W, Wagner M.
    Psychopharmacology (Berl); 2004 Oct 29; 175(4):399-406. PubMed ID: 15042278
    [Abstract] [Full Text] [Related]

  • 13. Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?
    Eker SS, Kirli S, Akkaya C, Cangur S, Sarandol A.
    World J Biol Psychiatry; 2009 Oct 29; 10(4 Pt 2):400-8. PubMed ID: 19670086
    [Abstract] [Full Text] [Related]

  • 14. Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine.
    Berlanga C, Flores-Ramos M.
    J Affect Disord; 2006 Oct 29; 95(1-3):119-23. PubMed ID: 16782204
    [Abstract] [Full Text] [Related]

  • 15. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment.
    Hetzel G, Moeller O, Evers S, Erfurth A, Ponath G, Arolt V, Rothermundt M.
    Psychopharmacology (Berl); 2005 Mar 29; 178(2-3):161-6. PubMed ID: 15316717
    [Abstract] [Full Text] [Related]

  • 16. Is there a role for a pure noradrenergic drug in the treatment of depression?
    Montgomery SA.
    Eur Neuropsychopharmacol; 1997 Apr 29; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305
    [Abstract] [Full Text] [Related]

  • 17. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.
    Aragona M, Bancheri L, Perinelli D, Tarsitani L, Pizzimenti A, Conte A, Inghilleri M.
    Eur J Pain; 2005 Feb 29; 9(1):33-8. PubMed ID: 15629872
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
    Taner E, Demir EY, Cosar B.
    Adv Ther; 2006 Feb 29; 23(6):974-87. PubMed ID: 17276965
    [Abstract] [Full Text] [Related]

  • 19. Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
    Crawford AA, Lewis S, Nutt D, Peters TJ, Cowen P, O'Donovan MC, Wiles N, Lewis G.
    Psychopharmacology (Berl); 2014 Aug 29; 231(15):2921-31. PubMed ID: 24525810
    [Abstract] [Full Text] [Related]

  • 20. Reboxetine: its effects as measured by the Social Adaptation Self-evaluation Scale.
    Healy D.
    Acta Psychiatr Scand Suppl; 2000 Aug 29; 402():45-51. PubMed ID: 10901159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.